CAD 0.03
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.00 CAD | 87.5% |
2022 | -0.03 CAD | 0.31% |
2021 | -0.03 CAD | -18.45% |
2020 | -0.03 CAD | -1835.71% |
2019 | -0.00 CAD | 86.0% |
2018 | -0.01 CAD | 58.33% |
2017 | -0.02 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.01 CAD | -100.0% |
2024 Q2 | -0.00 CAD | 4.0% |
2023 Q2 | 0.00 CAD | 433.33% |
2023 Q4 | -0.00 CAD | 40.48% |
2023 FY | - CAD | 87.5% |
2023 Q3 | -0.00 CAD | -205.0% |
2023 Q1 | -0.00 CAD | 90.63% |
2022 Q2 | -0.01 CAD | 8.7% |
2022 Q4 | -0.01 CAD | -120.69% |
2022 Q3 | -0.01 CAD | 7.94% |
2022 Q1 | -0.01 CAD | 72.94% |
2022 FY | - CAD | 0.31% |
2021 Q4 | -0.03 CAD | -2218.18% |
2021 FY | - CAD | -18.45% |
2021 Q2 | -0.00 CAD | -4.17% |
2021 Q1 | -0.00 CAD | 90.12% |
2021 Q3 | -0.00 CAD | 56.0% |
2020 Q3 | -0.00 CAD | -216.67% |
2020 Q2 | 0.00 CAD | 0.0% |
2020 Q1 | 0.00 CAD | 400.0% |
2020 FY | - CAD | -1835.71% |
2020 Q4 | -0.02 CAD | -3371.43% |
2019 Q3 | 0.00 CAD | 150.0% |
2019 Q4 | -0.00 CAD | -140.0% |
2019 FY | - CAD | 86.0% |
2019 Q2 | -0.00 CAD | -25.0% |
2019 Q1 | -0.00 CAD | 42.86% |
2018 Q2 | -0.00 CAD | 0.0% |
2018 FY | - CAD | 58.33% |
2018 Q4 | -0.00 CAD | 6.67% |
2018 Q3 | -0.00 CAD | -400.0% |
2018 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AI/ML Innovations Inc. | -0.06 CAD | 92.933% |
Diagnamed Holdings Corp. | -0.02 CAD | 75.46% |
Pangenomic Health Inc. | -0.30 CAD | 98.667% |
Treatment.Com International Inc. | -0.26 CAD | 98.462% |
Unidoc Health Corp. | -0.04 CAD | 91.091% |